Report Detail

Pharma & Healthcare Global Imipenem API Market Research Report 2020

  • RnM3932298
  • |
  • 18 March, 2020
  • |
  • Global
  • |
  • 121 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Imipenem API Market Overview

    • 1.1 Product Overview and Scope of Imipenem API
    • 1.2 Imipenem API Segment by Type
      • 1.2.1 Global Imipenem API Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Aseptic API
      • 1.2.3 Non-sterile API
    • 1.3 Imipenem API Segment by Application
      • 1.3.1 Imipenem API Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Intramuscular Injection
      • 1.3.3 Static Drops
    • 1.4 Global Imipenem API Market Size Estimates and Forecasts
      • 1.4.1 Global Imipenem API Revenue 2015-2026
      • 1.4.2 Global Imipenem API Sales 2015-2026
      • 1.4.3 Imipenem API Market Size by Region: 2020 Versus 2026

    2 Global Imipenem API Market Competition by Manufacturers

    • 2.1 Global Imipenem API Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Imipenem API Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Imipenem API Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Imipenem API Manufacturing Sites, Area Served, Product Type
    • 2.5 Imipenem API Market Competitive Situation and Trends
      • 2.5.1 Imipenem API Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Imipenem API Players (Opinion Leaders)

    3 Imipenem API Retrospective Market Scenario by Region

    • 3.1 Global Imipenem API Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Imipenem API Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Imipenem API Market Facts & Figures by Country
      • 3.3.1 North America Imipenem API Sales by Country
      • 3.3.2 North America Imipenem API Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Imipenem API Market Facts & Figures by Country
      • 3.4.1 Europe Imipenem API Sales by Country
      • 3.4.2 Europe Imipenem API Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Imipenem API Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Imipenem API Sales by Region
      • 3.5.2 Asia Pacific Imipenem API Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Imipenem API Market Facts & Figures by Country
      • 3.6.1 Latin America Imipenem API Sales by Country
      • 3.6.2 Latin America Imipenem API Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Imipenem API Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Imipenem API Sales by Country
      • 3.7.2 Middle East and Africa Imipenem API Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Imipenem API Historic Market Analysis by Type

    • 4.1 Global Imipenem API Sales Market Share by Type (2015-2020)
    • 4.2 Global Imipenem API Revenue Market Share by Type (2015-2020)
    • 4.3 Global Imipenem API Price Market Share by Type (2015-2020)
    • 4.4 Global Imipenem API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Imipenem API Historic Market Analysis by Application

    • 5.1 Global Imipenem API Sales Market Share by Application (2015-2020)
    • 5.2 Global Imipenem API Revenue Market Share by Application (2015-2020)
    • 5.3 Global Imipenem API Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Imipenem API Business

    • 6.1 Hospira
      • 6.1.1 Corporation Information
      • 6.1.2 Hospira Description, Business Overview and Total Revenue
      • 6.1.3 Hospira Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Hospira Products Offered
      • 6.1.5 Hospira Recent Development
    • 6.2 ACS DOBFAR SPA
      • 6.2.1 ACS DOBFAR SPA Imipenem API Production Sites and Area Served
      • 6.2.2 ACS DOBFAR SPA Description, Business Overview and Total Revenue
      • 6.2.3 ACS DOBFAR SPA Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 ACS DOBFAR SPA Products Offered
      • 6.2.5 ACS DOBFAR SPA Recent Development
    • 6.3 High Science
      • 6.3.1 High Science Imipenem API Production Sites and Area Served
      • 6.3.2 High Science Description, Business Overview and Total Revenue
      • 6.3.3 High Science Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 High Science Products Offered
      • 6.3.5 High Science Recent Development
    • 6.4 Jeil Pharmaceutica
      • 6.4.1 Jeil Pharmaceutica Imipenem API Production Sites and Area Served
      • 6.4.2 Jeil Pharmaceutica Description, Business Overview and Total Revenue
      • 6.4.3 Jeil Pharmaceutica Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Jeil Pharmaceutica Products Offered
      • 6.4.5 Jeil Pharmaceutica Recent Development
    • 6.5 Choongwae Pharma Corporation
      • 6.5.1 Choongwae Pharma Corporation Imipenem API Production Sites and Area Served
      • 6.5.2 Choongwae Pharma Corporation Description, Business Overview and Total Revenue
      • 6.5.3 Choongwae Pharma Corporation Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Choongwae Pharma Corporation Products Offered
      • 6.5.5 Choongwae Pharma Corporation Recent Development
    • 6.6 Sun Pharmaceutical
      • 6.6.1 Sun Pharmaceutical Imipenem API Production Sites and Area Served
      • 6.6.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
      • 6.6.3 Sun Pharmaceutical Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Sun Pharmaceutical Products Offered
      • 6.6.5 Sun Pharmaceutical Recent Development
    • 6.7 Sandoz
      • 6.6.1 Sandoz Imipenem API Production Sites and Area Served
      • 6.6.2 Sandoz Description, Business Overview and Total Revenue
      • 6.6.3 Sandoz Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Sandoz Products Offered
      • 6.7.5 Sandoz Recent Development
    • 6.8 Kaliberr
      • 6.8.1 Kaliberr Imipenem API Production Sites and Area Served
      • 6.8.2 Kaliberr Description, Business Overview and Total Revenue
      • 6.8.3 Kaliberr Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Kaliberr Products Offered
      • 6.8.5 Kaliberr Recent Development
    • 6.9 Auronext Pharma
      • 6.9.1 Auronext Pharma Imipenem API Production Sites and Area Served
      • 6.9.2 Auronext Pharma Description, Business Overview and Total Revenue
      • 6.9.3 Auronext Pharma Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 Auronext Pharma Products Offered
      • 6.9.5 Auronext Pharma Recent Development
    • 6.10 Nectar Lifesciences
      • 6.10.1 Nectar Lifesciences Imipenem API Production Sites and Area Served
      • 6.10.2 Nectar Lifesciences Description, Business Overview and Total Revenue
      • 6.10.3 Nectar Lifesciences Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Nectar Lifesciences Products Offered
      • 6.10.5 Nectar Lifesciences Recent Development
    • 6.11 Savior Lifetec Corporation
      • 6.11.1 Savior Lifetec Corporation Imipenem API Production Sites and Area Served
      • 6.11.2 Savior Lifetec Corporation Imipenem API Description, Business Overview and Total Revenue
      • 6.11.3 Savior Lifetec Corporation Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Savior Lifetec Corporation Products Offered
      • 6.11.5 Savior Lifetec Corporation Recent Development
    • 6.12 Zhuhai United Laboratorie
      • 6.12.1 Zhuhai United Laboratorie Imipenem API Production Sites and Area Served
      • 6.12.2 Zhuhai United Laboratorie Imipenem API Description, Business Overview and Total Revenue
      • 6.12.3 Zhuhai United Laboratorie Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Zhuhai United Laboratorie Products Offered
      • 6.12.5 Zhuhai United Laboratorie Recent Development
    • 6.13 SUZHOU HOMESUN PHARMACEUTICAL
      • 6.13.1 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Production Sites and Area Served
      • 6.13.2 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Description, Business Overview and Total Revenue
      • 6.13.3 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 SUZHOU HOMESUN PHARMACEUTICAL Products Offered
      • 6.13.5 SUZHOU HOMESUN PHARMACEUTICAL Recent Development
    • 6.14 Unimark Remedies
      • 6.14.1 Unimark Remedies Imipenem API Production Sites and Area Served
      • 6.14.2 Unimark Remedies Imipenem API Description, Business Overview and Total Revenue
      • 6.14.3 Unimark Remedies Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 Unimark Remedies Products Offered
      • 6.14.5 Unimark Remedies Recent Development
    • 6.15 Zhejiang Haixiang Pharmaceutical
      • 6.15.1 Zhejiang Haixiang Pharmaceutical Imipenem API Production Sites and Area Served
      • 6.15.2 Zhejiang Haixiang Pharmaceutical Imipenem API Description, Business Overview and Total Revenue
      • 6.15.3 Zhejiang Haixiang Pharmaceutical Imipenem API Sales, Revenue and Gross Margin (2015-2020)
      • 6.15.4 Zhejiang Haixiang Pharmaceutical Products Offered
      • 6.15.5 Zhejiang Haixiang Pharmaceutical Recent Development

    7 Imipenem API Manufacturing Cost Analysis

    • 7.1 Imipenem API Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Imipenem API
    • 7.4 Imipenem API Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Imipenem API Distributors List
    • 8.3 Imipenem API Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Imipenem API Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Imipenem API by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Imipenem API by Type (2021-2026)
    • 10.2 Imipenem API Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Imipenem API by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Imipenem API by Application (2021-2026)
    • 10.3 Imipenem API Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Imipenem API by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Imipenem API by Region (2021-2026)
    • 10.4 North America Imipenem API Estimates and Projections (2021-2026)
    • 10.5 Europe Imipenem API Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Imipenem API Estimates and Projections (2021-2026)
    • 10.7 Latin America Imipenem API Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Imipenem API Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Imipenem API market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on Imipenem API volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Imipenem API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Imipenem API market is segmented into
      Aseptic API
      Non-sterile API

      Segment by Application
      Intramuscular Injection
      Static Drops

      Global Imipenem API Market: Regional Analysis
      The Imipenem API market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Imipenem API market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Imipenem API Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Imipenem API market include:
      Hospira
      ACS DOBFAR SPA
      High Science
      Jeil Pharmaceutica
      Choongwae Pharma Corporation
      Sun Pharmaceutical
      Sandoz
      Kaliberr
      Auronext Pharma
      Nectar Lifesciences
      Savior Lifetec Corporation
      Zhuhai United Laboratorie
      SUZHOU HOMESUN PHARMACEUTICAL
      Unimark Remedies
      Zhejiang Haixiang Pharmaceutical


      Summary:
      Get latest Market Research Reports on Imipenem API. Industry analysis & Market Report on Imipenem API is a syndicated market report, published as Global Imipenem API Market Research Report 2020. It is complete Research Study and Industry Analysis of Imipenem API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $4,350.00
      $5,800.00
      2,133.33
      3,200.00
      4,266.67
      2,395.37
      3,593.06
      4,790.75
      300,970.70
      451,456.05
      601,941.40
      212,316.54
      318,474.81
      424,633.08
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report